Department of Veterinary Disease Biology, Faculty of Life Sciences, University of Copenhagen is offering a PhD project commencing 1/1 2011 or soon thereafter. The application deadline is December 1st 2010.
The Faculty of Life Science and Novo Nordisk A/S have recently established a research centre - The Novo Nordisk-LIFE In Vivo Pharmacology Centre (NNLIVPC) - with a total budget of DKK 68 mill covering activities until end 2018. The present positions are part of the new Centre´s activities. The purpose of the research centre is to strengthen the research in experimental pharmacology and toxicology and to increase the output of candidates and PhDs with a strong in vivo pharmacological profile. It is expected that the future PhD fellows will be enrolled in the In Vivo Pharmacology PhD program at LIFE and participate actively in this network. The In Vivo Pharmacology PhD program was established in 2006 as a collaboration between the Faculties of Life Sciences, Pharmaceutical Sciences and Health Sciences at the University of Copenhagen, University of Aarhus, and industrial partners; Novo Nordisk A/S, LEO Pharma and H. Lundbeck A/S.
Obesity, increased visceral fat mass, and liver steatosis (fat in liver) are factors associated with increased risk of developing cardiovascular disease. A common side effect following insulin therapy is weight gain - an issue for patients with type 2 diabetes as they often are obese when starting on insulin therapy. At present, the association between insulin-induced weight gain in type 2 diabetic individuals and the risk of developing cardiovascular disease is unclear.
With this project we wish to i) establish how insulin-induced obesity is associated with visceral fat mass and liver steatosis in an animal model of type 2 diabetes, ii) investigate how such changes are associated with relevant blood and tissue markers of inflammation and cardiovascular disease, and iii) investigate how insulin-induced weight gain in patients with type 2 diabetes is associated with changes in markers of cardiovascular disease.Contact:
Professor Jens Lykkesfeldt
Direct Phone: (+45) 35333163
Ph D Fellowship On The Diabetic Heart At The Lifepharm Centre, University of Copenhagen, Denmark, 8 days ago
Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen is offering a PhD fellowship commencing 1 October 2015 or soon thereafter. The applicat...
Ph D Student, Ghent University, Netherlands, 10 days ago
Job description RED AND PROCESSED MEAT IN THE DIET: TOXICOLOGICAL AND METABOLOMIC PROFILING UNDER SIMULATED GASTROINTESTINAL CONDITIONS Collaboration between UGent, Laboratory for Animal Nutrition...
Ph D Scholarships In Yeast Strain And Process Development, Technical University of Denmark (DTU), Denmark, 21 days ago
PhD Scholarships in Yeast Strain and Process Development Marie Curie Actions Co-fund. More Marie Curie Actions. More European Research Council. More 'HR Excellence in Research' logo awarded to ins...
Ph D Scholarships In Synthetic Biology Tools For Cell Factory Development, Technical University of Denmark (DTU), Denmark, 29 days ago
Marie Curie Actions Co-fund. More Marie Curie Actions. More European Research Council. More 'HR Excellence in Research' logo awarded to institutions actively implementing the European Charter and ...
Ph D Studentship: Induced Bone Stem Cells From Normal, Aged And Diseased Populations, The University of Southampton, United Kingdom, 11 days ago
Human Development & Health Location: Southampton General Hospital Closing Date: Friday 10 July 2015 Interview Date: Reference: 584815AF Interview Date: Tuesday 14th July Project Description: New ...
Ph D Position Nanoparticle Induced Fibrosis In Ex Vivo Models (1.0 Fte) : Groningen, Netherlands, Rijksuniversiteit Groningen, Netherlands, 28 days ago
Job posted by universitypositions (05/06/2015 10.10) Marie Curie Actions. More 'HR Excellence in Research' logo awarded to institutions actively implementing the European Charter and Code for Rese...